Ublituximab for the treatment of CD20 positive B-cell...

  • Main
  • 2018 / 04
  • Ublituximab for the treatment of CD20 positive B-cell...

Ublituximab for the treatment of CD20 positive B-cell malignancies

Babiker, Hani M., Glode, Ashley E., Cooke, Laurence S., Mahadevan, Daruka
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Expert Opinion on Investigational Drugs
DOI:
10.1080/13543784.2018.1459560
Date:
April, 2018
File:
PDF, 893 KB
english, 2018
Conversion to is in progress
Conversion to is failed